Welcome to LookChem.com Sign In|Join Free
  • or
α-Benzyl-β-hydroxy-γ-butyrolactone is a cyclic ester compound with the molecular formula C11H16O3. It features a butyrolactone ring structure, where the α-position is occupied by a benzyl group, the β-position has a hydroxyl group, and the γ-position is part of the lactone ring. This organic compound is known for its potential applications in the synthesis of various pharmaceuticals and natural products due to its unique structural features. It can be used as a building block in organic synthesis, particularly in the preparation of complex molecules that require a chiral center or a specific stereochemistry. The compound's reactivity and stability make it a valuable intermediate in the development of new drugs and other chemical products.

78986-57-9

Post Buying Request

78986-57-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78986-57-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 78986-57-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,9,8 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78986-57:
(7*7)+(6*8)+(5*9)+(4*8)+(3*6)+(2*5)+(1*7)=209
209 % 10 = 9
So 78986-57-9 is a valid CAS Registry Number.

78986-57-9Downstream Products

78986-57-9Relevant academic research and scientific papers

Mechanistic insight into the inactivation of carboxypeptidase A by α-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity

Chung,Chung,Hyun Soo Lee,Kim,Kyung Seok Oh,Hyuk Soon Choi,Kim,Yeoun Jin Kim,Jong Hoon Hahn,Kim

, p. 6462 - 6471 (2007/10/03)

On the basis of the active site topology and enzymic catalytic mechanism of carboxypeptidase A (CPA), a prototypical zinc-containing proteolytic enzyme, α-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid (1), was designed as a novel type of mechanism-based inactivator of the enzyme. All four possible stereoisomers of the inhibitor were synthesized in an enantiomerically pure form starting with optically active aspartic acid, and their CPA inhibitory activities were evaluated to find that surprisingly all of the four stereoisomers inhibit CPA in a time dependent manner. The inhibited enzyme did not regain its enzymic activity upon dialysis. The inactivations were prevented by 2-benzylsuccinic acid, a competitive inhibitor that is known to bind the active site of the enzyme. These kinetic results strongly support that the inactivators attach covalently to the enzyme at the active site. The analysis of ESI mass spectral data of the inactivated CPA ascertained the conclusion from the kinetic results. The values of second-order inhibitory rate constants (kobs/[I]o) fall in the range of 1.7-3.6 M-1 min-1. The lack of stereospecificity shown in the inactivation led us to propose that the ring cleavage occurs by the nucleophilic attack at the 2-position rather than at the 5-position and the ring opening takes place in an addition-elimination mechanism. The tetrahedral transition state that would be generated in this pathway is thought to be stabilized by the active site zinc ion, which was supported by the PM3 semiemprical calculations. In addition, a-benzyl-2-oxo-1,3-oxazolidine-5-acetic acid (18), a structural isomer of i was also found to inactivate CPA in an irreversible manner, reinforcing the nucleophilic addition-elimination mechanism. The present study demonstrates that the transition state for the inactivation pathway plays a critical role in determining stereochemistry of the inactivation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 78986-57-9